The clinical features of this disease are primarily caused by excess IGF-1 production, a hormone secreted in the liver in response to GH; in addition to the hypertrophic effects of IGF-1 on tissue, excess GH results in metabolic complications including insulin resistance. Here, IGF1 is linked to Insulin resistance.